LIC Portfolio: In the June quarter of the financial year 2025-26 (FY26), Life Insurance Corporation of India’s (LIC) share in NSE-listed companies declined in percentage terms — highlighting profit taking by India’s biggest domestic institutional investor (DII) amid a sharp rise in the stock market during the said quarter.
According to data by primeinfobase.com, LIC’s holding in companies listed on NSE went down to 3.68% as on June 30, 2025, from 3.72% as on March 31, 2025, despite a net buy of ₹9,914 crore.
Top LIC stock picks in Q1 FY26
PSUs and two Adani stocks dominated the list of the companies where LIC increased its stake the most during the quarter under review.
LIC raised its stake from below 1% to up to 8% in nearly four of its top purchases in Q1, with Bharat Petroleum Corporation (BPCL) topping the list. BPCL was the top addition in the LIC portfolio in Q1 FY26, as the insurance giant’s stake in the company swelled to 8.44% in the June quarter from less than 1% in the March 2025 quarter.
Similarly, in Mazagon Dock, too, its stake went up from less than 1% to 3.27% on a quarter-on-quarter (QoQ) basis. Firstsource Solutions, PCBL and IREDA are among the other three stocks where the LIC stake jumped from below 1% to 3.65%, 2.81% and 2.21%, respectively.
Adani group stocks — ACC and Ambuja Cement — were also among the other top additions in the LIC portfolio in Q1, as its stake in these companies increased by 1.42% and 1.24% to 9.11% and 6.78%, respectively.
Tata group stock, Voltas, and Baba Ramdev-led Patanjali Foods also saw an increase in stake addition by LIC. Lastly, BLS International was among the other top stock picks of LIC in Q1.
Top LIC stock sells in Q1 FY26
On the flip side, chemical, pharma and healthcare companies were among the top stocks where LIC reduced its stake the most in the June quarter. These sectors have been in the limelight in the light of tariffs announced by US President Donald Trump, and are expected to face significant brunt from his policies.
Meanwhile, three companies saw their holding reduced to below 1% in LIC’s stock portfolio in Q1 FY26. These included Sanofi Consumer Healthcare, Yes Bank and Lupin.
Meanwhile, LIC trimmed its stake in both Navin Fluorine and SRF to 7.85% and 3.07% in Q1, selling 1.96% and 1.65% stake, respectively.
Divi’s Labs, Marico, Apollo Hospitals, Eicher Motors and Capri Global were among other top stocks where LIC reduced its stake dramatically.
Disclaimer: This story is for educational purposes only. The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
